TrialOrphanet journal of rare diseases2018

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.

Yi Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.